GLAXF (GLAXF) Stock Price & Analysis
GLAXF (GLAXF) fell 1.67% to USD 23.54 as of June 10, 2026 at 02:31 UTC, according to Nexqual real-time market data.
GLAXF last closed at USD 23.94; the session ranged USD 23.54–23.54 on volume of 4 shares. Market capitalization is $94.37B, with a 52-week range of USD 17.15–31.48 (PNK). Source: Nexqual, June 10, 2026 at 02:31 UTC.
Key Statistics (as of June 10, 2026 at 02:31 UTC)
| Price | USD 23.54 |
|---|---|
| Change | ▼ 1.67% (down) |
| Previous Close | USD 23.94 |
| Open | USD 23.54 |
| Day Range | USD 23.54 – 23.54 |
| 52-Week Range | USD 17.15 – 31.48 |
| Volume | 4 shares |
| Market Cap | $94.37B |
| Exchange | PNK |
Technical Analysis (GLAXF)
Nexqual's technical model rates GLAXF "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 02:31 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 37.56 (neutral) |
| vs SMA50 | Below (USD 26.54) |
| MACD | -0.57 (negative) |
Analyst Ratings (GLAXF)
Wall Street analysts rate GLAXF "None", per Nexqual as of June 10, 2026 at 02:31 UTC.
| Consensus Rating | None |
|---|
Earnings (GLAXF)
| Next Earnings Date | 2026-07-28 |
|---|---|
| Revenue Estimate | $8.23B |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financials & Fundamentals (GLAXF)
| Total Revenue | $32.78B |
|---|---|
| Revenue Growth (YoY) | +1.50% |
| Gross Margin | +72.87% |
| Operating Margin | +36.28% |
| Profit Margin | +17.78% |
| ROE | +40.91% |
| Debt / Equity | 109.7 |
| Current Ratio | 0.79 |
| Total Cash | $3.44B |
| Total Debt | $19.11B |
| Free Cash Flow | $3.02B |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financial Health Score (GLAXF)
Nexqual rates GLAXF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:31 UTC.
| Growth | Mixed — Revenue +4.1% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 36% |
| Balance Sheet | Weak — $3.44B cash vs $19.1B debt |
| Cash Flow | Solid — FCF $3.02B, 9% margin |
| Efficiency | Strong — ROE 41%, ROA 10.0% |
Ownership (GLAXF)
| Insider Ownership | +1.75% |
|---|---|
| Institutional Ownership | +46.60% |
| Shares Outstanding | 4.01B |
| Float | 3.89B |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Leadership (GLAXF)
GLAXF is led by Luke Victor Miels (age 51), CEO & Director, per Nexqual as of June 10, 2026 at 02:31 UTC.
| CEO & Director | Luke Victor Miels (age 51) |
|---|---|
| CFO & Executive Director | Julie Belita Brown A.C.A. (age 63) |
| Chief Scientific Officer and Head of R & D | Tony Wood |
| President of Corporate Development | David Simon Redfern BSc (Hons), CA (age 59) |
Major Backers & Investors (GLAXF)
Notable institutional backers of GLAXF include Dodge & Cox Funds-Dodge & Cox International Stock Fund, Fidelity, MFS Series Trust XVII-MFS International Equity Fund, according to Nexqual as of June 10, 2026 at 02:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Dodge & Cox Funds-Dodge & Cox International Stock Fund | 1.85% |
| Fidelity | 1.04% |
| MFS Series Trust XVII-MFS International Equity Fund | 0.41% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.49% |
| BlackRock | 1.07% |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNYNF | Sanofi | USD 88.5 | ▲ 0.9% |
| NVSEF | Novartis AG | USD 148.8 | ▲ 2.71% |
| MKKGY | Merck KGaA | USD 32 | ▲ 2.11% |
| BPAQF | BP Plc | USD 6.83 | ▼ 5.27% |
| NONOF | Novo-Nordisk A/S | USD 41.6 | ▼ 4.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:31 UTC. This page is informational and not investment advice.